hotspot -WSS

hotspot

author：hotspot 2025-08-23 08:56:45 - browse：752

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Cano Health’s bankruptcy is a warning for Medicare Advantage

explore

focus

WSS

Global cancer cases to surge 77% by 2050, WHO report says

Readout LOUD: Venture capital, Gilead, and more M&A

Padmanee Sharma of MD Anderson at center of lawsuit over credit

AI gets buy

Stem cell clinics for heart failure: buyer be wary

Medicare Advantage plans can’t deny care with AI, CMS warns

focus

hotspot

hotspot

How one medical school became remarkably diverse

Biden calls for immediate release of Niger's president amid apparent coup

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Influencer to be charged after chaos erupts in New York City's Union Square

The cancer drug shortage isn’t new — and neither are the solutions

2 US Navy sailors arrested for allegedly spying for China

Trump demands the U.S. pay no more for drugs than other countries … again

Johnson & Johnson sued for allegedly overpaying for workers' drugs

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

2 US Navy sailors arrested for allegedly spying for China

focus

For BCIs, commercial hurdles may be bigger than scientific ones

What’s missing from the debate over nursing home staff minimums

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Humana, CVS hope to turn members into patients at clinics

Global cancer cases to surge 77% by 2050, WHO report says

explore

focus

focus

hotspot